Ajanta Pharma gets nod for share buyback plan of up to Rs 286 crore

28 Dec 2021 Evaluate

Ajanta Pharma’s board has approved a share buyback plan of up to Rs 286 crore, wherein the drug maker will buy back shares at a maximum price of Rs 2,550 apiece. The total pay-out towards buyback of shares will be not exceeding Rs 356 crore, including a share buyback consideration not exceeding Rs 286 crore and tax not exceeding Rs 70 crore, on a proportionate basis through the tender offer process.

Ajanta Pharma is a specialty pharmaceutical company engaged in development, manufacturing and marketing of quality finished dosages.

Ajanta Pharma Share Price

1683.60 -27.45 (-1.60%)
May 16, 18:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 885.75
Cipla 933.10
Dr. Reddy's Lab 3887.25
Aurobindo Pharma 550.75
Lupin 684.65
View more..